SCHEMBL1389987

SCHEMBL1389987

Cc1cc(Cl)ccc1C(C/C(=N/O)c1ccc(=O)n(C)c1)c1ccc(C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 3/20 0.46
CREBBP Q92793 1/20 0.38
PTGER4 P35408 4/20 0.35
PTGDR Q13258 3/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
F11 P03951 2/20 0.34
PHGDH O43175 1/20 0.34
EGFR P00533 1/20 0.34
POLB P06746 2/20 0.33
PRKCZ Q05513 1/20 0.33
KLKB1 P03952 1/20 0.33
FFAR1 O14842 3/20 0.33
BRD4 O60885 1/20 0.32
MEN1 O00255 1/20 0.32
CYP2C9 P11712 1/20 0.32
KMT2A Q03164 1/20 0.32
PTGER2 P43116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389988 1.00 GPBAR1 (0.46) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL1389985 1.00 GPBAR1 (0.46) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL1390130 0.97 GPBAR1 (0.51) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL10241335 0.97 GPBAR1 (0.51) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL369930 0.97 GPBAR1 (0.51) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL369931 0.97 GPBAR1 (0.51) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL10241339 0.97 GPBAR1 (0.51) GPBAR1CREBBPPTGER4PTGDRKEAP1
SCHEMBL15832829 0.92 GPBAR1 (0.40) GPBAR1CREBBPKEAP1NFE2L2EGFR
SCHEMBL370281 0.91 GPBAR1 (0.51) GPBAR1CREBBPKEAP1NFE2L2EGFR
SCHEMBL370280 0.91 GPBAR1 (0.51) GPBAR1CREBBPKEAP1NFE2L2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885CREBBP 2198/4885PTGER4 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.